A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
Edits on 21 Jul, 2023
"Remove website redirecting to Patent Public Search front page"